Patients treated with a combination of capecitabine and temozolomide had more progression-free survival rates compared to those treated with temozolomide only.
from Medindia Health News https://ift.tt/6wr0gt9
LATEST HEALTH NEWS
Reviewed by MZ Digital Marketing Agency
on
June 06, 2022
Rating: 5
No comments
Thanks for comment via will connect you within 24 hours.
No comments
Thanks for comment via will connect you within 24 hours.